Search Results - "ABDALLA, Eddie K"
-
1
One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States
Published in Journal of clinical oncology (20-06-2008)“…PURPOSE Neuroendocrine tumors (NETs) are considered rare tumors and can produce a variety of hormones. In this study, we examined the epidemiology of and…”
Get full text
Journal Article -
2
High Survival Rate After Two-Stage Resection of Advanced Colorectal Liver Metastases: Response-Based Selection and Complete Resection Define Outcome
Published in Journal of clinical oncology (10-03-2011)“…Prolonged survival after two-stage resection (TSR) of advanced colorectal liver metastases (CLM) may be the result of selection of best responders to…”
Get full text
Journal Article -
3
Margin Status Remains an Important Determinant of Survival After Surgical Resection of Colorectal Liver Metastases in the Era of Modern Chemotherapy
Published in Annals of surgery (01-06-2013)“…OBJECTIVE:To determine the impact of surgical margin status on overall survival (OS) of patients undergoing hepatectomy for colorectal liver metastases after…”
Get full text
Journal Article -
4
Improving resectability of hepatic colorectal metastases: expert consensus statement
Published in Annals of surgical oncology (01-10-2006)Get full text
Journal Article -
5
Hepatic Insufficiency and Mortality in 1,059 Noncirrhotic Patients Undergoing Major Hepatectomy
Published in Journal of the American College of Surgeons (01-05-2007)“…Background To establish a reliable definition of postoperative hepatic insufficiency (PHI) in noncirrhotic patients undergoing major hepatectomy. No standard…”
Get full text
Journal Article -
6
Surgical Strategies for Synchronous Colorectal Liver Metastases in 156 Consecutive Patients: Classic, Combined or Reverse Strategy?
Published in Journal of the American College of Surgeons (01-06-2010)“…Background An increasing number of patients with synchronous colorectal liver metastases (CLM) are candidates for resection. The optimal treatment sequence in…”
Get full text
Journal Article -
7
Pathologic Response to Preoperative Chemotherapy: A New Outcome End Point After Resection of Hepatic Colorectal Metastases
Published in Journal of clinical oncology (20-11-2008)“…The primary goal of this study was to evaluate whether pathologic response to chemotherapy predicts patient survival after preoperative chemotherapy and…”
Get full text
Journal Article -
8
Comparison of CT Methods for Determining the Fat Content of the Liver
Published in American journal of roentgenology (1976) (01-05-2007)“…The purpose of this study was to assess which of a number of methods of measuring attenuation on CT scans is best for prediction of hepatic fat content. This…”
Get full text
Journal Article -
9
Borderline Resectable Pancreatic Cancer: The Importance of This Emerging Stage of Disease
Published in Journal of the American College of Surgeons (01-05-2008)“…Background Patients with borderline resectable pancreatic adenocarcinoma (PA) include those with localized disease who have tumor or patient characteristics…”
Get full text
Journal Article -
10
Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma
Published in Annals of surgery (01-07-2007)“…To better understand the impact of a microscopically positive margin (R1) on patterns of disease recurrence and survival after pancreaticoduodenectomy (PD) for…”
Get full text
Journal Article -
11
Long-Term Survival After Multidisciplinary Management of Resected Pancreatic Adenocarcinoma
Published in Annals of surgical oncology (01-04-2009)“…Introduction Actual 5-year survival rates of 10–18% have been reported for patients with resected pancreatic adenocarcinoma (PC), but the use of multimodality…”
Get full text
Journal Article -
12
Chemotherapy Regimen Predicts Steatohepatitis and an Increase in 90-Day Mortality After Surgery for Hepatic Colorectal Metastases
Published in Journal of clinical oncology (01-05-2006)“…Chemotherapy before resection of hepatic colorectal metastases (CRM) may cause hepatic injury and affect postoperative outcome. Four hundred six patients…”
Get full text
Journal Article -
13
Resection of liver metastases from breast cancer: Estrogen receptor status and response to chemotherapy before metastasectomy define outcome
Published in Surgery (01-05-2012)“…Background The oncologic benefit of resecting liver metastases in patients with breast cancer is unclear. This study was performed to identify predictors of…”
Get full text
Journal Article -
14
Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases
Published in Annals of surgery (01-06-2004)“…To examine recurrence and survival rates for patients treated with hepatic resection only, radiofrequency ablation (RFA) plus resection or RFA only for…”
Get full text
Journal Article -
15
Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases
Published in Annals of surgery (01-05-2005)“…To evaluate the influence of surgical margin status on survival and site of recurrence in patients treated with hepatic resection for colorectal metastases…”
Get full text
Journal Article -
16
Simultaneous resections of colorectal cancer and synchronous liver metastases: a multi-institutional analysis
Published in Annals of surgical oncology (01-12-2007)“…The safety of simultaneous resections of colorectal cancer and synchronous liver metastases (SCRLM) is not established. This multi-institutional retrospective…”
Get full text
Journal Article -
17
Clinical and Prognostic Implications of Plasma Insulin-Like Growth Factor-1 and Vascular Endothelial Growth Factor in Patients With Hepatocellular Carcinoma
Published in Journal of clinical oncology (10-10-2011)“…Cirrhosis and hepatocellular carcinoma (HCC) together form a two-disease state that affects survival of patients with HCC and dictates treatment decisions and…”
Get full text
Journal Article -
18
Preoperative Bevacizumab Does Not Significantly Increase Postoperative Complication Rates in Patients Undergoing Hepatic Surgery for Colorectal Cancer Liver Metastases
Published in Journal of clinical oncology (10-11-2008)“…Although bevacizumab (BV) increases survival rates when used with chemotherapy (CTX) in patients who have metastatic colorectal cancer (CRC), an increase in…”
Get full text
Journal Article -
19
Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma
Published in Liver transplantation (01-09-2005)“…Vascular invasion and high histologic grade predict poor outcome after surgical resection or liver transplantation for hepatocellular carcinoma (HCC). Despite…”
Get full text
Journal Article -
20
Pretreatment assessment of hepatocellular carcinoma: expert consensus statement
Published in HPB (Oxford, England) (01-06-2010)“…Staging of hepatocellular carcinoma (HCC) is complex and relies on multiple factors including tumor extent and hepatic function. No single staging system is…”
Get full text
Journal Article Conference Proceeding